|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01830 PERFECT MEDICAL
Nominal 
2.620 0.000 (0.000%) | 2023/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | 2020/09 HKD(K$) | 2019/09 HKD(K$) | |
| Turnover | 718,149 | 7.459% | 668,300 | 801,644 | 509,807 | 708,054 |
| Cost of Sales | -- | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- | -- |
| 2023/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | 2020/09 HKD(K$) | 2019/09 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 203,767 | 12.626% | 180,924 | 267,746 | 170,089 | 301,221 | |
| Taxation | (37,374) | 23.485% | (30,266) | (51,332) | (34,454) | (58,342) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 166,393 | 10.444% | 150,658 | 216,414 | 135,635 | 242,879 | |
| 2023/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | 2020/09 HKD(K$) | 2019/09 HKD(K$) | |
| Net Finance Costs / (Income) | (1,834) | -- | 6,122 | 7,069 | 1,603 | 3,366 |
| Depreciation & Amortisation | 102,679 | -10.021% | 114,115 | 102,381 | 81,711 | 71,371 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2023/09 - Interim | %Chg (Compare to Interim) | 2022/09 | 2021/09 | 2020/09 | 2019/09 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2023/09 - Interim | %Chg (Compare to Interim) | 2022/09 | 2021/09 | 2020/09 | 2019/09 | |
| EPS (cts) | 13.200 | 9.091% | 12.100 | 17.700 | 12.100 | 21.800 |
| DPS (cts) | 14.200 | -- | 13.000 | 17.700 | 13.000 | 0.000 |
| Dividend Payout Ratio (%) | 107.576% | -- | 107.438% | 100.000% | 107.438% | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.430 | -- | 0.480 | 0.696 | 0.748 | 0.533 |
| Remarks: | Real time quote last updated: 25/11/2024 08:25 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 315,800 |
| %Change | 0.051% |
| EPS / (LPS) | HKD 0.251 |
| NBV Per Share ($) | HKD 0.396 |